Comparable Alternatives, Cost Effectiveness, and Clinical Trial Data: The Medicare Prescription Drug Bill Changes the Reimbursement Landscape
September 1, 2004
Michael M. Gaba- Washington
Holland & Knight partner Michael Gaba authored the following article appearing in the Food and Drug Law Institute's Update Magazine. Click on the link below to view this article.
http://www.hklaw.com\content/whitepapers/medicarechanges.pdf